Valiant Laboratories Ltd.
VALIANTLAB Share PricePharmaceuticals & Drugs
₹64.57
-0.5 (-0.8%)
As on December 4, 2025
Exchange Scrips: BSE543998NSEVALIANTLABISININE0JWS01017
Market Cap ₹ 350 Cr
P/E Ratio -137.32
Dividend Yield N/A
Performance
Market performance
Open66.38
High67.9
Volumes47,431
Prev64.57
Low64.01
As on2025-12-04
Historical performance
1 Year High120.92
3 Year High199.64
5 Year High199.64
1 Year Low63.86
3 Year Low63.86
5 Year Low63.86
Fundamentals
Company Valuation
Market Cap (₹Cr)
350
Face Value (₹)
10
P/E Ratio
-137.32
Dividend Yield
N/A
Investment Returns
1 Year
-40.7%
3 Years
N/A
5 Years
N/A
10 Years
N/A
Technicals
| Indicators | Value | Signal |
|---|---|---|
| 5-DMA | 66.17 | Bearish |
| 10-DMA | 68.15 | Bearish |
| 20-DMA | 74.15 | Bearish |
| 50-DMA | 80.13 | Bearish |
| 100-DMA | 85.69 | Bearish |
| 200-DMA | 88.82 | Bearish |
Shareholding Pattern
| Field | Sep-2025 | Jun-2025 | Mar-2025 | Dec-2024 | Sep-2024 |
|---|---|---|---|---|---|
| Promoters | 8 | 8 | 8 | 8 | 8 |
| Foreign Investors | --- | --- | --- | --- | --- |
| Domestic Investors | 8 | 8 | 8 | 8 | 8 |
| Public Investors | 15067 | 14424 | 15028 | 15684 | 15181 |
| Government | --- | --- | --- | --- | --- |
Financials
Below figures are in Rs. Crores
Balance Sheet
Below figures are in Rs. Crores
Cash Flow
Below figures are in Rs. Crores
0%
Negative
Neutral
Positive
- The stock has a PE ratio of -137.32.
- 3Y Stock Price CAGR of the stock is -36.1.
- The stock has a beta of 0.9.
- In the last financial year, the company had an EBITDA of ₹8 Million.
- The company generated revenue of ₹1334 Million in the previous financial year.
Valiant Laboratories Ltd.
64.57-0.5 (-0.8%)
₹
Investment Amount: ₹ 1000000
Current Value: ₹ 598407.8
No. of Shares: 9268 (Approx)
Performance:-40.2%
P/L: ₹-401592.2
Top Gainers
Peer Comparison
Get Your Portfolio Reviewed
